Rallybio Balance Sheet Analysis

Assets, liabilities, and stockholders equity in millions USD

Scroll to see more
Balance sheet showing assets, liabilities, and shareholders' equity for Rallybio Corporation (RLYB) - Annual data in millions USD
BreakdownFY 2024FY 2023FY 2022FY 2021FY 2020
Period EndingDec 2024Dec 2023Dec 2022Dec 2021Dec 2020
Current Assets
Cash and Cash Equivalents13.90109.9356.96175.33140.23
Short-Term Investments51.6185.44112.040.000.00
Cash & Short-Term Investments65.51109.93168.99175.33140.23
Accounts Receivable0.000.000.000.000.00
Inventory0.000.000.000.000.00
Other Current Assets0.642.051.051.841.03
Total Current Assets67.84114.79179.50180.87141.26
Non-Current Assets
Property, Plant & Equipment (Net)0.270.590.910.510.29
Long-Term Investments0.000.240.030.810.31
Other Non-Current Assets0.000.000.000.000.00
Total Non-Current Assets0.270.830.941.320.00
Total Assets68.11115.62180.44182.19141.86
Current Liabilities
Accounts Payable0.289.041.110.601.58
Short-Term Debt0.150.000.000.000.00
Accrued Liabilities4.964.904.755.953.27
Deferred Revenue0.850.000.000.000.00
Other Current Liabilities4.960.000.000.000.99
Total Current Liabilities6.249.2610.746.555.84
Non-Current Liabilities
Long-Term Debt0.000.170.370.000.00
Other Non-Current Liabilities0.000.000.000.030.01
Total Non-Current Liabilities0.210.170.370.030.00
Total Liabilities6.459.4411.126.585.86
Stockholders' Equity
Common Stock0.000.000.000.000.00
Retained Earnings-293.02-235.23-160.68-94.03-47.01
Accumulated Other Comprehensive Income0.070.02-0.210.000.00
Additional Paid-in Capital354.60341.41330.21269.630.00
Shares Outstanding41.5137.8337.8432.130.00
Total Stockholders' Equity61.65106.18169.32175.60136.00
Total Liabilities & Equity68.11115.62180.44182.190.00